Using a detailed dissection of cellular signaling pathways in vitro, we demonstrated that S6K1 is a key component of a multi-kinase targeting strategy in sfRon expressing ovarian tumors. This evidence concerns the gene RPS6KB1 and ovarian neoplasm.